Received: from AS8PR02MB7254.eurprd02.prod.outlook.com (2603:10a6:20b:3fb::15) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Sat, 10 Oct 2026 21:56:57 +0000 Received: from DUZPR01CA0011.eurprd01.prod.exchangelabs.com (2603:10a6:10:3c3::19) by AS8PR02MB7254.eurprd02.prod.outlook.com (2603:10a6:20b:3fb::15) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.472.15; Sat, 10 Oct 2026 21:56:52 +0000 Received: from DU2PEPF00028D02.eurprd03.prod.outlook.com (2603:10a6:10:3c3:cafe::e) by DUZPR01CA0011.outlook.office365.com (2603:10a6:10:3c3::19) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.496.5 via Frontend Transport; Sat, 10 Oct 2026 21:56:52 +0000 Received: by mail-vk1-f176.google.com with SMTP id 71dfb90a1353d-5e23be41cf8so356954e0c.2 for ; Sat, 10 Oct 2026 14:56:50 -0700 (PDT) Received: from mail1.rit.ee (213.184.53.4) by DU2PEPF00028D02.mail.protection.outlook.com (10.167.242.186) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.522.6 via Frontend Transport; Sat, 10 Oct 2026 21:56:51 +0000 From: "Gafur Jafarli" To: "Info - SOM" Subject: SNB Global Health Passport: Estonia Integration and Chronic-Care Pilot Proposal Date: Sun, 11 Oct 2026 00:56:37 +0300 Keywords: Mall Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0027_01DD5A3C.14CD2830" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQKZs2wm8UoefwpHLAx9QLnY4wKkow== Authentication-Results: mx.microsoft.com 1; spf=softfail (sender IP is 213.184.53.4) smtp.mailfrom=gmail.com; dkim=pass (signature was verified) header.d=gmail.com;dmarc=pass action=none header.from=gmail.com;compauth=pass reason=100 X-CSE-ConnectionGUID: xTciYOxoTj2cvGGEmYF1NA== X-CSE-MsgGUID: f7qWBo7iSZahtUibxsxUCA== X-IronPort-AV: E=Sophos;i="6.27,150,1787000400"; d="scan'208,217";a="82633796" X-MS-Exchange-Organization-ExpirationStartTime: 10 Oct 2026 21:56:52.0776 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 3a2f4306-8d29-44b4-c25f-08df27196453 X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: DU2PEPF00028D02:EE_|AS8PR02MB7254:EE_|DB9PR02MB7817:EE_ X-MS-Exchange-Organization-AuthSource: DU2PEPF00028D02.eurprd03.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: 3a2f4306-8d29-44b4-c25f-08df27196453 X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Organization-SCL: -1 X-Microsoft-Antispam: BCL:0;ARA:13230040|704162111799003|260918224100599003|260918215300599003|7093399015|82310400026|10067099003|4128699003|11063799006|5063699009|56012099006|19002099009|6133799003|16102099003|55112099003|18002099003|8096899003|3613699012|261009223027099003; X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:en;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(704162111799003)(260918224100599003)(260918215300599003)(7093399015)(82310400026)(10067099003)(4128699003)(11063799006)(5063699009)(56012099006)(19002099009)(6133799003)(16102099003)(55112099003)(18002099003)(8096899003)(3613699012)(261009223027099003);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 10 Oct 2026 21:56:51.8995 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 3a2f4306-8d29-44b4-c25f-08df27196453 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DU2PEPF00028D02.eurprd03.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS8PR02MB7254 X-MS-Exchange-Transport-EndToEndLatency: 00:00:05.8178060 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0496.018 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710232)(4717077)(4999285)(920097)(930201)(20251009284)(140003); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?kmC54It5L1YYYvehdW8MwGz3vPuN4AgzeAQ8Ptnz6MOB0Qx0i2kSsdckO+3J?= =?us-ascii?Q?93o/oeB925AAshQiSVZYV0E+oF3cRmuVQ/10I8eTu0iFTcGNGv5I/nQls51E?= =?us-ascii?Q?mmD5EbwfqyvziuNHDR/ffFSRdlTWYT1r43v//FIKFlOs3ch7gGUoKtjPOF+h?= =?us-ascii?Q?kOQRuAvzm6MSTVAGVedCVxCdSzbGcYD8SVEWKexUPzTp1uQsqap7VBZEdrDi?= =?us-ascii?Q?X9+r+NgiKuotqDeSpMrO3JnwMaELsGFgfbabmoCEvrgkTdy0zqsXLUNSYgpY?= =?us-ascii?Q?Hh3l2p09x2RTlG0+NB014zChifsW3HdD0J3/8ywkGIxupthY2ycdFm3LFCPz?= =?us-ascii?Q?EI4DAcLeXy+/L6Uao0iBZQeMhGlgwqtcAl079grJ8T0kg0KDbPxhhN9o52Jw?= =?us-ascii?Q?p8ZeSN4Q4BMe87W2bTrUD3blivqOtSx1CE7offArL3htj0p6BDliAkndFUcF?= =?us-ascii?Q?y42eh0zwwEy0x3ARlMyQVhrDKwuMXwobk35ZNrk0HgOwcfZbO2m2N48eCnsh?= =?us-ascii?Q?HxwO5Aq35QH39aUa5Qgckdar+xr6FJ2nxUgjOiuEjBIpHncAUuU0mxpyvu9h?= =?us-ascii?Q?GlfnU3gbmX3jYgC64qEqIpINv20HBdhq6FrHv/AzsBtTSaoNNt+2b+mcOipd?= =?us-ascii?Q?Ktlzd/UUvOKNI8RyJCO1PSOKF62sNxbeAEW1VmpSAXgfaxA1mY2ZuTlR1urw?= =?us-ascii?Q?odPPBVVHVyQ4PLlK3i7QLRpqoUBG+PoY9VjrsoOnpQLBSzq8vmm n5l8dlo7/?= =?us-ascii?Q?AvsFZ/vdsj+U/6r4sEqv4yXpHcsUMSKU9pyG/bG82Cemyo5I0kkZ09GbY9Fj?= =?us-ascii?Q?jll4Qgcsp4z2r/uPE3zDxVC5mrIDywOj00na7fGcG/cBPEV79rCEV1LeHI6i?= =?us-ascii?Q?/Ctt9CytDfff/Qb/8HemHPXcMpOeKgXDqDpIpfE1GZbPIdOblbiD8rEnxo0Y?= =?us-ascii?Q?5TPZ7jjU7KFZn35EttPLgfOnNBYVzWAjidOGHPWxr1e/gGCCUumOpRTubMWe?= =?us-ascii?Q?MT9shndZ+GdSrr6X6NgsSSRKZOQJCQUWhU71Dqr32/z+/2hk7Binspx1uJYq?= =?us-ascii?Q?JtIICBBtiYCXUhr76GHcLUzw9i/7xRSGolQLlqAdiMHD4glyDV9vmXjJBt9h?= =?us-ascii?Q?Vk0jvXzePDE1//jOaaRfjcJg2E7Os7vQPsv/ItuXzmfJBZIrB+iBpOOTaAki?= =?us-ascii?Q?JG5AhrzQCCqGxWSIwXs49evyPoiG+cIRBE9Ny0RZDfQjYxviUwfpccnu4DpN?= =?us-ascii?Q?x2itcdA2Mq1sgvZVGdT/XEZrKTaEosTOcFChijtxKqvDf1BQK/AOyP1XBkmG?= =?us-ascii?Q?dSNA0L7a96k2DXgV5/y1hL6Vr5N235Uw8j6wGBeqxbLa4JW0Ka+6a4FQvRlK?= =?us-ascii?Q?YNyyd6t1nJIqFZN742aXY82mBI9083coRFKq3ABp3L1tAmCKxtYhwH40wlzl?= =?us-ascii?Q?LZCcdx473tcPYldG48Al9iXz7mKZsp7VcUDtSxWTRZxvI1EUaM8Y6LxEER6J?= =?us-ascii?Q?U8edt8B7dZi3pDiBJgsOkM94U68OUBd2CisOb OFTt/6kcPM+YXyDWBfQe0vy?= =?us-ascii?Q?r7TQB/62DAYMCTDjkis5O4AMNROiIflpLCp72lGnTfXA/cvZ4EidqNr3qgNj?= =?us-ascii?Q?pBfxIH63GM3U7cB8DEpPSGgUtPJjmATp7n9kPA/JofgCbgS8uVOyOKNC4dj9?= =?us-ascii?Q?JXBHVkwvj4ACO+ZmNRB3h2t7zXk9pRYLzvoZJIFIYc6v8X/yrKk33i+410JG?= =?us-ascii?Q?7tsourbZaXmyuOROUB9Dim+r6RPGmBhVaiMr+lpOxANUaTTPvZOH0vFHspKH?= =?us-ascii?Q?OhWlPCBaWA+uvjW5Oth5aLr+we8CujD5Q7QsDgOhoSqbtt/7Dku2oIZco8uU?= =?us-ascii?Q?PPTyJk9OX12TKSnEnB2SgG9hUQuXLi5ALcUug0Nx8qckb2TOHie/cBJYu0R/?= =?us-ascii?Q?W6qGjVTrxZsP2IaUyTwLBRH6SNV7pJGFBtXEMVtuT6th82w0ATuA1sqirm1f?= =?us-ascii?Q?o3zzfJW9Kki3E0TRDZ1bEKscR6BDm/xruoRseE7JDT3q/vUZsyMW7QnHhnUy?= =?us-ascii?Q?4vm0XQQ0U1svIFqe962x+XAy6tqbw9LYF5jJMVC4J2NcNeMy26iYL7svLeo1?= =?us-ascii?Q?BzJllyGwRIGWhFZdE0sjmyi96jNtqt55Hz4QRy2V5J1tYz/p6IjcxepjvCgb?= =?us-ascii?Q?ujWL72DFMeIcnS/n70PQrBqdNDIfTnx4IcXse95xfxrlaGbxIaLuJNHD3y1P?= =?us-ascii?Q?0AqiQGC7bTOpKw1u9llkF0gK7I7u5BuYl1WLPSl0ZD2PO8qtGMy977WS9lE1?= =?us-ascii?Q?dUC9cy/ndzpg4KJ3yoeXRxu reyGKGrZ/pBRpDAv5xyBJovY3J0mF0mZTagvM?= =?us-ascii?Q?PjZnedrkQmpCxFUKkc4RHwyJUN7GjEmdCqPYD9KMNS3UwEHZ1OCwHUZYZ4vc?= =?us-ascii?Q?9JvOB0sBJ0UfBnwy+RlO65lBymTYCzEHUY7l8gd6i0H1SEczNt284BUQBL/Y?= =?us-ascii?Q?szZQNzyg/JM59ul62YrriT5upRb0mGPRdQvXt1n7s65LJCEWMpF56pODxhu/?= =?us-ascii?Q?S49gXP+O+wqHRe/Q/K4+8TYJjQjSetjN/IWifKf6F5rPZx+m9zpPHTu7YeiY?= =?us-ascii?Q?5QU1eR20VHRUy0J6bW2Hg6V9BoMvdcDXxWNUSQLSMMg89mtR31bjmvGX4bBf?= =?us-ascii?Q?vTNu/qobbhwFMgHvBUEoL2OThtW/Vz91TcfUnqSNJIKTxGbkZk2A8PW1W+62?= =?us-ascii?Q?8rDKilMBX9AigNTQBwqB4Xsr9FaI+MpiU9dD7uDHCD1dMn7+6z8wGo+4faVX?= =?us-ascii?Q?I2YrquWYKJ0BxhllxKrfl/2x1/Ahk38TQqc=3D?= Content-Language: en-us x-ms-exchange-organization-originalclientipaddress: 213.184.53.4 x-ms-exchange-organization-originalserveripaddress: 10.167.242.186 received-spf: None (mail1.rit.ee: no sender authenticity information available from domain of postmaster@mail-vk1-f176.google.com) identity=helo; client-ip=209.85.221.176; receiver=mail1.rit.ee; envelope-from="drgafurjafarli@gmail.com"; x-sender="postmaster@mail-vk1-f176.google.com"; x-conformance=spf_only dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=gmail.com; s=20251104; t=1791669409; x=1792274209; darn=sm.ee; h=content-type:to:subject:message-id:date:from:mime-version:from:to :cc:subject:date:message-id:reply-to:content-type; bh=3xIAazbtXfNPm1i+llioXWx6S9wPZEWkXpAwTKryS7U=; b=IKof+WzMUoxHpcAYu6UlCEiKWqwDABUPRFkMuKFgcgJhq1s2CW7rL4abA5efwCkEsY 6wTJZ4t1UJyFPzMFh1oXkHgVzXsRG+i0tBcYjD3UuPh8PJqlGInMePLEDl/mJY16/1xN UntQrbX97ld4WH2wnTKtfcTXlNVnzkm5D2gqOtDtHVKBRVQQDajEj3Fwu3Ka70RuAI17 RcN1/d5whYCZfm7ZEwjg/P2DNKON4Ql16zzB7ryTtGiwO+Vv/jDN9uljnroMQ3WH4Xwc a0SQCrrwmAW7jeGeZ7QRfxp+y5ZDBjCm2nzgtBUswPBkX3L1gaccm/aJzPxF1zj0EC9x dXwQ== X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D90000000011210000040B7DFBC7D8274694B433B1D16F507B X-ThreatScanner-Verdict: Negative X-IPAS-Result: =?us-ascii?q?A0FEBgBvs8pqgbDdVdFQCh0BATwBBQUBAgEJAYFngj+CH?= =?us-ascii?q?wRUhFiBI5BQi3qSJBOBKz0CDwEBAQEBAQEBHgE8BAEBAwQ3AQaEOwOOFyAHA?= =?us-ascii?q?UsBAgECAQMCAwEBAQEBAQEBAQEBAQoBAQEEAQEBAgEBAgQDAQEBAQIQAQEiG?= =?us-ascii?q?QcOO4YVCDIBDIwTgSxhAgUDOwEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBA?= =?us-ascii?q?QEBAQEBAQEBAQUCLIEIHQEbBBEJAxIJBzcCIgEBEQEFASIThSUBBhABAze/J?= =?us-ascii?q?oEVBQIWgQGCDQYFAwIB2mAKGSgNdYEMXAIHFoE4gnWCAw0dXQGCPiABgWABA?= =?us-ascii?q?g6EQIUGgg2BFTWDNIIfgWoFAQcLAYN8gmoEgiKBDIMnkksmCAcXAwcHCQUEH?= =?us-ascii?q?AYFBQI/CQUBDxIDBAMEBAECCwkKCQMDAg4CCAMCCAYZAT8SBBMKDQsHBR8KA?= =?us-ascii?q?gwUCigiEisKAQIBKSwDLQEIBgICBAQCBAwCCQICBQcCEQMEAQEIAgItAwEDG?= =?us-ascii?q?QgJCAILBREYDAsHMQMQCQMfFwgOCBE0CAYDEwEaBgUGCzcVBQwRAQIbAh8EH?= =?us-ascii?q?REIAwEGDgQCAQkDBBYEAhQKHwIDAwYDCgkCBQMbGAQBAgIDAgECCAMHCAMNA?= =?us-ascii?q?wQCAwMDBAECAgEBAQIDAQMDBAcCAQMHAgIDAwMLAQIDAwUDAwUFAgIFBQMFA?= =?us-ascii?q?gIKAgMDAwIBAwIaCAMGAxIBEAMDBgEDBwMHAgQDCQIIAwMICAMXAwMFAQICA?= = ?us-ascii?q?wEDAwgIBAMDBAICAwwFAwIDAwUDAwcCBAIEAwMBBQECBwIDBwIBGAMCBAgHB?= =?us-ascii?q?wUCCwQCCAQNCQQCBAICDwQGAwMHAQECAQcFBgMCAhABCAoFBgICAhwDHgMNB?= =?us-ascii?q?gEJBQIBBQ4HBQICGAMGAgMGBQEDAQoLAQECAwoBAgQCBQMDAQMCAwIGAwMCB?= =?us-ascii?q?QUFAwkHBQ4JAQMDBgUCAQEDAgMBAggEBgUDAgIDBQEDAwQDCQEDAggDAwgDD?= =?us-ascii?q?AIaAgUDAwMGCQMHBwIDBwMCBQIHBQMDBQMGAQMCAQMDCAsVHwMDAQUDAwIBA?= =?us-ascii?q?wIFAwMYAgIEBQMDAwMDCAQCAgEHBgQCAgIBBQUFBAUGAgQDCAEBBQMDCg0BA?= =?us-ascii?q?gcMAwwGAwcDAwQEAwIFCgIEAQcNBwkHAwIDBwEBCwQBAwMKAwMFAgEBBwUDB?= =?us-ascii?q?gMHAgMDAwUEBQMCCwMHAgIDAwMCJwEBAQMDAwMDBAMBAwEDAwcDBQMCEAcBA?= =?us-ascii?q?QoDAgYDBwYDBQMDAgECAwMFEQMGBAUGFwIGETIBCAIDAwEUBAQFAgUVAggBA?= =?us-ascii?q?wUDAwMDAgUDAQUBAQMDBQMDAwMDAwQBAwQCAwcGCAEBAQIIAwMCBQMDAwQDA?= =?us-ascii?q?wIBDQQCBQMGAgIEAgQBBwMBAgIDAwMDAQIEBAIHBAUCDAMEAgMDBQIDAgMLB?= =?us-ascii?q?gILBAIDAwMDAw0BAgsGAxQFCQQIBQMPBQEFBwcJAQMIBQMGAwsDFAMDBgMDA?= =?us-ascii?q?woEAgUBBhAMDgQBAgQJAwICBAIPFQQEAwcCDQsBAQQPCQgTPQELB zIENgEVF?= =?us-ascii?q?AUpIV+RIB6DOD8eNTczFz1QIZMGESENkXmIJQWXenFpgz+VA4ZdhhYzqWEla?= =?us-ascii?q?Yg4kFAjkXCRKxiFXDUSgWB4cDMaI4EBgjZQAxkPgU2QV8wedD0BAQcCBw4DC?= =?us-ascii?q?4FokDSBTAEB?= X-Talos-CUID: 9a23:EfLhtWDSWWKEdxH6Ezlb/08lPdAiTn+Hx2n/DGK9OEgwbpTAHA== X-Talos-MUID: =?us-ascii?q?9a23=3AUh29Kg24EmIKOjUGcwqzwbkcFzUj7fu3N2oKzpQ?= =?us-ascii?q?9icCEKRFxMSeGnAmca9py?= X-IronPort-Anti-Spam-Filtered: true X-Amp-Result: SKIPPED(no attachment in message) X-Amp-File-Uploaded: False X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20260707; t=1791669409; x=1792274209; h=content-type:to:subject:message-id:date:from:mime-version:x-gm-gg :x-gm-message-state:from:to:cc:subject:date:message-id:reply-to :content-type; bh=3xIAazbtXfNPm1i+llioXWx6S9wPZEWkXpAwTKryS7U=; b=oSWtLq0EKZFGvT6q+2C78yJz6+ciUZl3cD04IPBkTQWnVNCqZ2DgqwQ+t18iQdARmC JukGNrc7pI1fLS075SK+Ac6g6ZuvmLqVxnOny1b5daa8izzhVU+wsrCcAgrIOGMleDUi J1ifW1xAsUuS/y256B04kHFMyS3N/gkxljr9l2/JmZZKBVlCTUrCvVx63q3d9lj0a2FI NwIMH2jXewSY0g8ltVc37RDTILOWq/NFH1/LIqb2ZHQOko1wjW2f+97Q9dL/y25GNQaf pYBdgZltiiTP5UgDbD8ItTkZDvblA7pSVilAn2Q+MmGJ72FP7QXgd8QplKX5wJDLHoKK Bebw== X-Gm-Message-State: AFq9FYLLSV5r6jpXX8B0X299aJDJZCcNKKaf4iGTue0134eHs3i27gFz +3ibfscBd6nqchoq+Q8M7Gzl0VbvezKi85ajb0B6uyKi2wLV8U/Vxg+oE4uKXP3elOeSmCRwZ7n wJDregaAdrI38cI0SwFeAUeM4K44CUSt0OOa0Rz4= X-Gm-Gg: AYBFou1vxII2gpMdN1uHulLYX9I3A/lJW5HoqPmIEdUe2ZAmOuUY3v1aLVacgEBijH+ M0GAU1Ca4DdUpyCPy9y0dHd+6T240R39z87uWjZQh+2vG6o4hVrbT+JyfoDJVsV0zRV8hsZrgOY IOaJ+6nbySoj85Hha+UC7b9CIuawpoAeaq6ouhXzOhya+SfuNBeX7yXelnNQ4YFGsWQPem6y1MC E70yxnu6zq9xNpah/lOT6cpb4C2V8mpuOedu3oqRk5AMtSX0mB1j4q7upDWwMZ26351CcGDWgZD z7aVh7Y1neKoM5lNKQy3XC84ZVp3SG9wYzW5K37BJpozTty62iz7 X-Received: by 2002:a05:6102:3713:b0:7a6:cd7e:72db with SMTP id ada2fe7eead31-7cb3a117852mr1658613137.26.1791669409170; Sat, 10 Oct 2026 14:56:49 -0700 (PDT) X-Gm-Features: AclHuK9ymrLBlf0QXwk9Ytysg4_E1V0wIRi0qfl9h-7VyvDYKFoutTTeVFH5TuI X-DisclaimerOO: 1 X-Message-Completed: Mon, 12 Oct 2026 11:23:00 +0300 This is a multipart message in MIME format. ------=_NextPart_000_0027_01DD5A3C.14CD2830 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear Ministry of Social Affairs Team, I am Dr. Gafur Jafarli, a physician with 30 years of clinical experience and leadership as a CEO and owner of private hospitals. I hold professional certificates in cardiology, internal medicine, neurology, endocrinology and phlebology obtained in Azerbaijan and Russia, including Baku and Moscow. I am also a full member of the European Medical Association in Belgium and hold its certificates. I would welcome cooperation with Estonian clinical and digital health partners on the SNB Global Health Passport. We propose a 12-month pilot involving 1,000 patients with hypertension and a separate cohort of 1,000 patients with type 2 diabetes. Each participant would be counted once. The pilot would assess integration with existing records and the value of connecting personal risk assessment, physician-led care plans and systematic follow-up of abnormal findings. AI would assist clinical teams; locally licensed physicians would lead care. Independent evaluation would measure clinical control, follow-up completion, clinician workload and total costs. Our ambition is to test a 20% reduction in avoidable chronic-care costs, including programme costs, compared with usual care. My purpose is to contribute clinical experience to a scalable public-health service. I seek no personal award or honorarium and propose that an agreed share of verified net savings support sustainable delivery and wider access. I would welcome an introductory meeting to identify a local partner and develop a jointly costed pilot consistent with GDPR and Estonian clinical and regulatory requirements. Kind regards, Dr. Gafur Jafarli Owner and CEO, Avrasiya Hospital Founder, SNB Alliance Baku, Azerbaijan Email: gafurjafarli@gmail.com Phone / WhatsApp: +994 50 211 57 75 ------=_NextPart_000_0027_01DD5A3C.14CD2830 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable

T=C3=A4helepanu! Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.
Dear Ministry of Social Affairs Team,

I am Dr. Gafur Jafarli, a physician with 30 years of clinical experience = and leadership as a CEO and owner of private hospitals. I hold = professional certificates in cardiology, internal medicine, neurology, = endocrinology and phlebology obtained in Azerbaijan and Russia, including Baku and Moscow. I am also a full member of the = European Medical Association in Belgium and hold its certificates.

I would welcome cooperation with Estonian clinical and digital health = partners on the SNB Global Health Passport.

We propose a 12-month pilot involving 1,000 patients with hypertension = and a separate cohort of 1,000 patients with type 2 diabetes. Each = participant would be counted once.

The pilot would assess integration with existing records and the value = of connecting personal risk assessment, physician-led care plans and = systematic follow-up of abnormal findings. AI would assist clinical = teams; locally licensed physicians would lead care.

Independent evaluation would measure clinical control, follow-up = completion, clinician workload and total costs. Our ambition is to test = a 20% reduction in avoidable chronic-care costs, including programme = costs, compared with usual care.

My purpose is to contribute clinical experience to a scalable = public-health service. I seek no personal award or honorarium and = propose that an agreed share of verified net savings support sustainable = delivery and wider access.

I would welcome an introductory meeting to identify a local partner and = develop a jointly costed pilot consistent with GDPR and Estonian = clinical and regulatory requirements.

Kind regards,

Dr. Gafur Jafarli
Owner and CEO, Avrasiya Hospital
Founder, SNB Alliance
Baku, Azerbaijan
Email: gafurjafarli@gmail.com
Phone / WhatsApp: +994 50 211 57 75
------=_NextPart_000_0027_01DD5A3C.14CD2830--